Pancreatic Ductal Adenocarcinoma
Novel blood test could be first step to early detection of pancreatic cancer
A novel, rapid blood test demonstrated potential for detecting early-stage pancreatic cancer, according to results of a retrospective study.
High-dose IV vitamin C doubles pancreatic cancer survival
The addition of high-dose IV vitamin C to standard chemotherapy nearly doubled OS for patients with advanced pancreatic cancer, according to results of a randomized phase 2 trial.
Pancreatic Cancer Awareness Month: Upstaging common; keto diet may help shrink tumors
November is Pancreatic Cancer Awareness Month.
‘Be very suspicious’: Staging of early pancreatic cancer inaccurate up to 80% of the time
Nearly 80% of individuals clinically diagnosed with stage I pancreatic ductal adenocarcinoma and close to 30% diagnosed with stage II disease got upstaged after surgery, according to retrospective study results.
‘Persuasive’ data show screening high-risk individuals improves pancreatic cancer outcomes
Surveillance of individuals at a high risk for pancreatic ductal adenocarcinoma led to the detection of smaller, earlier-stage tumors, according to results of a comparative cohort study.
Body fat, metabolic changes before pancreatic cancer diagnosis may aid in early detection
In the 36 months prior to diagnosis of pancreatic ductal adenocarcinoma, researchers observed “predominant changes” in patients’ body composition and biochemical markers, which may serve as potential biomarkers for early cancer detection.
Prompt identification of new-onset diabetes may aid early detection of pancreatic cancer
WASHINGTON — An algorithm that uses electronic health record parameters identified glycemic evidence of new-onset diabetes in real time, which could lead to earlier detection of pancreatic ductal adenocarcinoma, according to researchers.
Novel blood test shows promising accuracy for detection of early-stage pancreatic cancer
A next-generation biomarker-based blood test demonstrated 98% specificity and 75% sensitivity in detecting stage I and II pancreatic ductal adenocarcinoma, according to a press release from the manufacturer.
New blood test close to ‘cracking the code’ on pancreatic cancer early detection
An investigational exosome-based liquid biopsy showed better than 90% accuracy for detecting early-stage pancreatic cancer among U.S.-based participants in a prospective multicenter study.
Glecirasib shows ‘impressive’ activity in certain patients with pancreatic cancer
Glecirasib exhibited antitumor activity among patients with pancreatic ductal adenocarcinoma and other solid tumors harboring the KRAS G12C mutation variant, study findings presented at ASCO Gastrointestinal Cancers Symposium showed.